Johnson Controls Tops Q3 Estimates and Lifts Full-Year Outlook on Surging Orders
JCI sits 45% above its 52-week low of $102.09.
Summary
Johnson Controls posted Q3 adjusted EPS of $1.42 on 10% organic sales growth, raised full-year guidance, and recorded a 27% order surge—a clear beat-and-raise quarter that reinforces the company's growth trajectory.
Key Events · Earnings and Guidance · JCI
-
Q3 Earnings Beat
Driven by 10% organic sales growth to $6.6 billion, adjusted EPS reached $1.42, exceeding the prior quarter's consensus of $1.12.
-
Full-Year Guidance Raised
FY2026 adjusted EPS guidance was lifted to ~$5.05 from ~$4.85, with organic sales growth now expected at ~8%, up from ~6%.
-
Orders Surge 27%
Organic orders jumped 27% year-over-year, pushing backlog to $21.0 billion—a 32% organic increase—fueled by data center and mission-critical demand.
-
Q4 Guidance Initiated
Q4 adjusted EPS guidance was set at ~$1.55, implying continued strong performance with 9-10% organic sales growth.
Analysis · JCI · Technology
A standout quarter saw organic sales climb 10% and orders surge 27%, propelling adjusted EPS to $1.42—well above the $1.12 consensus from last quarter. Reflecting confidence in sustained momentum, management raised full-year adjusted EPS guidance to ~$5.05 from ~$4.85 and initiated Q4 guidance of ~$1.55. The backlog swelled 32% organically to $21 billion, underpinned by data center and mission-critical demand. This report confirms the business is accelerating, not merely recovering, and the raised outlook suggests the strong cycle has further to run.
At the time of this filing, JCI was trading at $148.32 on NYSE in the Technology sector, with a market capitalization of approximately $85.6B. The 52-week trading range was $102.09 to $151.18. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.